SCHEMBL4791016

SCHEMBL4791016

NCC=Cc1cccc2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.49
GRIK2 Q13002 1/20 0.49
RXRA P19793 1/20 0.49
SMPD2 O60906 2/20 0.48
GRIN2D O15399 2/20 0.47
GRIN3B O60391 2/20 0.47
GRIN1 Q05586 2/20 0.47
GRIN2A Q12879 2/20 0.47
GRIN2B Q13224 2/20 0.47
GRIN2C Q14957 2/20 0.47
GRIN3A Q8TCU5 2/20 0.47
CHAT P28329 3/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
MTNR1A P48039 1/20 0.45
MTNR1B P49286 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23460038 0.85 CHAT (0.47) GRIK1GRIK2RXRASMPD2CHAT
SCHEMBL10706687 0.80 CHAT (0.62) RXRACHATHDAC8HDAC6MTNR1A
SCHEMBL10706694 0.80 CHAT (0.62) RXRACHATHDAC8HDAC6MTNR1A
SCHEMBL10706700 0.80 CHAT (0.62) RXRACHATHDAC8HDAC6MTNR1A
SCHEMBL7006267 0.80 RXRA (0.49) GRIK1GRIK2RXRASMPD2CHAT
SCHEMBL1683792 0.80 SMPD2 (0.54) GRIK1GRIK2RXRASMPD2CHAT
SCHEMBL15338325 0.80 SMPD2 (0.54) GRIK1GRIK2RXRASMPD2CHAT
SCHEMBL615456 0.80 SMPD2 (0.51) GRIK1GRIK2RXRASMPD2CHAT
SCHEMBL6002917 0.80 RXRA (0.49) GRIK1GRIK2RXRASMPD2CHAT
SCHEMBL615455 0.80 SMPD2 (0.51) GRIK1GRIK2RXRASMPD2CHAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014001075-A1 PROCESS FOR RACEMIZING OPTICALLY ACTIVE ARYLALKYLAMINES BASF SE (DE) 2014-01-03 WO disclosed
JP-2008214296-A MODULATOR FOR AUTOINDUCER-2 RECEPTOR OSAKA UNIV 2008-09-18 JP disclosed
EP-0318234-A2 Improvements in or relating to selective serotonin uptake inhibitors ELI LILLY AND COMPANY (US) 1989-05-31 EP disclosed